Abstract
The phagocytosis of dying cells is an integral feature of apoptosis and necrosis. There are many receptors involved in recognition of dying cells, however, the molecular mechanisms of the scavenging process remain elusive. The activation by necrotic cells of complement is well established, however, the importance of complement in the scavenging process of apoptotic cells was just recently described. Here we report that the complement components C3 and C4 immediately bound to necrotic cells. The binding of complement was much higher for lymphocytes compared to granulocytes. In case of apoptotic cell death complement binding was a rather late event, which in lymphocytes was preceded by secondary necrosis. Taken together complement binding is an immediate early feature of necrosis and a rather late event during apoptotic cell death. We conclude that complement may serve as an opsonin for fragments of apoptotic cells that have escaped regular scavenging mechanisms. Cell Death and Differentiation (2001) 8, 327–334
Similar content being viewed by others
Introduction
Physiological cell death usually proceeds by the process of apoptosis. After an initial phase of commitment to cell death the execution phase is characterised by distinct structural changes.1 Recognition and removal by phagocytes is the final common event of the death program. Genetic studies of C. elegans revealed that at least six out of 14 genes regulating apoptosis are necessary for engulfment of apoptotic cells, highlighting the importance of their clearance.2 The fast and efficient removal of apoptotic cells results in a low steady state of dying cells even in tissues of mass apoptosis like the thymus.3 Both macrophages and neighbouring semi-professional phagocytes4,5,6,7,8 usually remove cells undergoing apoptosis before membrane integrity is lost.9 Thereby, fast recognition, uptake, and nonphlogistic degradation promote the resolution of inflammation.10,11 If phagocytosis is insufficient to remove apoptotic cells in the early phases of cell death, noxious cell contents may leak and cause severe tissue damage and autoimmunity.9,12 This is of major importance for the removal of aged granulocytes containing high amounts of toxic compounds.13,14 Lectin-like molecules, the receptors for thrombospondin (CD36) and vitronectin (αVβ3 and αVβ5),15,16 class A and B scavenger receptors,17 the ATP-binding cassette transporter ABC1,18 as well as CD1419 have all been described to recognise surface changes on apoptotic cells. Since phagocytosis of apoptotic lymphocytes by macrophages is stereospecifically inhibited by phosphatidyl-L-serine liposomes, a specific receptor is supposed to be involved in phosphatidylserine (PS) recognition.20 In addition, β2-glycoprotein, annexins and gas-6 may serve as adaptor proteins.21 Antibodies recognising either phospholipid of β2-glycoprotein-I were able to opsonise apoptotic cells and substantially enhanced their immunogenicity.22,23
Surface blebs of apoptotic cells have been shown to contain high amounts of autoantigen that had been modified in the execution phase of apoptotic cell death.24,25,26,27,28 Furthermore, keratinocytes undergoing apoptosis develop the capacity to bind C1q in the absence of antibodies.29 This complement factor was supposed to influence the immune response to self-antigens comprised within surface blebs of apoptotic cells.30 In animals with targeted deletion of C1q, impaired clearance of apoptotic cells and a mild form of nuclear autoimmunity were observed.31 Furthermore, it was shown that complement was able to augment the in vitro uptake of apoptotic cells by monocyte-derived macrophages.32
Here, we investigated the complement binding of necrotic and apoptotic cells in different states of cell death. To induce necrosis of polymorphonuclear cells (PMN) and of peripheral blood lymphocytes (PBL) cells were treated with heat shock. PBL apoptosis had to be induced by ultraviolet B light (UVB) irradiation whereas in PMN apoptosis occurred spontaneously during some hours of in vitro culture (ageing process). We demonstrated that the binding of the complement factors C1q, C3 and C4 to aged PMN and apoptotic PBL is a very late event in apoptosis. In contrast, induction of necrosis by heat shock resulted in an immediate binding of complement, more pronounced in PBL than in PMN. Analysis of C5 binding revealed that the membrane attack complex was not activated by apoptotic or necrotic cells, respectively.
Results
Complement does not change the morphology of the cultured cells
Untreated PMN (Figure 1a) as well as irradiated PBL (Figure 1b) underwent apoptotic cell death during culture. While apoptosis was proceeding, PMN as well as PBL underwent morphological changes resulting in a typical decrease of the forward scatter (FSC) concomitant with an increase in side scatter (SSC) as detected by flow cytometry (viable cells: population 1, apoptotic cells: population 2, subcellular fragments: population 3) (Table 1). In ageing PMN these changes occur faster than in UV-B irradiated PBL and the population 2 is much less pronounced (Figure 1). In the late phases of apoptosis, cells disintegrated resulting in numerous subcellular fragments with reduced FSC/SSC (marked with 3 in Figure 1a,b). A different behaviour could be seen in necrotic PMN compared to necrotic PBL. Compared to viable PMN, necrotic PMN showed a slightly decreased SSC and a markedly reduced FSC (Table 1a). In contrast, necrosis of PBL resulted in a moderate increase in SSC and a decrease in FSC (Table 1b). In comparison to cultures in medium containing 10% heat inactivated fetal calf serum (R10) neither active nor heat inactivated autologous serum exerted relevant influences on the FSC and SSC properties of all populations (Figure 1c,d).
Time course of apoptosis and necrosis
Table 2 summarises the properties of the three distinct populations defined in Figure 1 and Table 1. Most PBL in population 1 are viable (annexin-Vneg (AxV)neg, propidium iodideneg (PI)neg, mitochondrial membrane potentialhigh (Δψm)high), whereas populations 2 and 3 mainly consist of apoptotic (AxVpos, PIneg, Δψmlow) or secondary necrotic (AxVpos, PIlow, Δψmlow) cells. Since primary necrotic cells (AxVpos, PIpos) can clearly be distinguished from populations 2 and 3 by the Δψm (Table 2a) and the FSC/SSC properties (Figure 1 and Table 1), PIlow cells of both populations are referred to as secondary necrotic cells.
The major differences between UVB irradiated PBL and in vitro aged PMN are the low amounts of secondary necrotic cells and the relative stability of the Δψm in PMN. Even incubation for 30 min at 56°C yielded only 64% of primary necrotic PMN, defined by permeability for PI (Table 2b). Importantly, neither addition of freshly isolated nor inactivated serum to the culture medium (RPMI-1640 supplemented with 10% heat inactivated fetal calf serum (R10)) markedly influenced annexin V binding, PI permeability, Δψm (data not shown), or FSC/SSC properties (Figure 1 and Table 1).
We used loss of Δψm (staining with fluorescent dye 3,3′-dihexyloxacarbocyanine iodide (DiO6C(3))), exposure of PS (staining with AxV-FITC (fluorescein isothiocyanate)), dye exclusion (staining with PI in the absence of detergent), nuclear granularity and hypochromicity (NGH) (staining with PI in the presence of detergent) as markers for apoptotic and necrotic cell death. As shown in Figure 2a, 42 h after UVB irradiation with 120 mJ/cm2 more than 70% of the PBL displayed reduction of Δψm, exposure of PS and nuclear changes. Less than 20% of the cells displayed a primary necrotic phenotype. In late phases (100 h after UV-B irradiation) PI binding in absence of detergent increased.
In cultured PMN apoptosis proceeds faster than in UVB irradiated PBL. After 29 h of culture more than 70% of the PMN exposed PS and more than 90% showed nuclear changes. Only 44% of PMN had reduced Δψm. The membrane integrity was preserved in most PMN at this time point since more than 92% of the cells excluded PI (Figure 2b).
Complement binds subcellular fragments of PBL generated during the very late phases of apoptotic cell death
To detect complement binding, cells were stained with affinity purified, FITC labelled antibodies against C1q, C3c, C4c and C5 (Figure 3). Heat treated primary necrotic lymphocytes showed a strong binding of C3 and C4, whereas there was very little binding of C1q and C5. In contrast, irradiated lymphocytes displayed only a weak binding of complement for the first 52 h of culture. During this period most PBL had undergone apoptosis and many of them already displayed a primary (PIpos) or secondary necrotic (PIlow) phenotype (Table 2). However, between 52 and 72 h many subcellular fragments were formed (population 3), which bound C1q, C3 and C4 (Figure 3 and Table 2). C5 was not detected on UVB irradiated PBL. PBL of population 2 showed weak binding of C1q and those of population 1 never showed any complement binding (Figure 3 and Table 2a). Therefore, morphological changes, PS exposure, nuclear hypochromicity and loss of mitochondrial membrane potential precede the complement binding of irradiated lymphocytes. The latter appeared to be focused on small subcellular fragments that are generated during the very late phases of apoptotic cell death.
In addition to UVB induced apoptosis we analyzed the complement binding of PBL undergoing either spontaneous apoptosis or apoptosis induced by staurosporine. Although the kinetics of apoptosis differed considerably between all three protocols, the complement binding was focused on subcellular fragments in all cases (data not shown). When we performed the experiments with up to 30% human serum in R10, we also observed a strong specific complement binding only for subcellular fragments (data not shown).
Complement mainly binds subcellular fragments generated during in vitro culture of PMN
Ageing PMN retained their membrane integrity much longer than apoptotic PBL (Table 2). Concerning complement binding apoptotic PMN showed some striking differences to UVB irradiated PBL (Figure 4). Interestingly, necrotic PMN bound much less C3 and C4 compared to necrotic PBL. A low binding of C3 and C4 was observed as early as 1 h and a low C1q binding was detected after 13 h of in vitro culture of PMN that had remained in the viable cell gate (population 1). However, during prolonged culture subcellular fragments were generated that showed a very high C3 and a high C4 binding activity. In addition, these fragments moderately bound C1q and C5 (Figure 4 and Table 2b). Although a weak C1q, C3, and C4 binding was observed in the early phases of apoptotic cell death, high complement binding to PMN was a late event during apoptosis preceded by PS exposure and nuclear hypochromicity. In contrast to PBL most of the PMN binding complement still excluded PI.
Discussion
In vivo cells undergoing apoptosis are timely recognised and swiftly ingested while still intact, thereby protecting tissues from the potentially harmful exposure to the contents of the dying cell.15 The clearance of dying cells is mainly performed by professional phagocytes like macrophages. In addition, apoptotic corpses are also taken up by neighbouring cells acting as semi-professional phagocytes.9 Many receptors and adaptor molecules have been reported to be involved in the fast and efficient removal of apoptotic cells in various tissues (reviewed in33). Recently, the receptor involved in PS recognition on apoptotic cells was identified.20 The clearance of apoptotic cells is usually non-phlogistic.34,35 In contrast, cells with disintegrated membranes have been shown to release proinflammatory substances capable to activate dendritic cells and thereby function as natural adjuvants.36 Therefore, the non-inflammatory clearance of apoptotic cells has to be completed before the loss of membrane integrity. Granulocytes contain huge amounts of toxic compounds and are constitutively programmed to undergo apoptosis. Therefore, the removal of apoptotic neutrophils and eosinophils is a prerequisite for the resolution of inflammatory responses.10
Mice with targeted disruption of the C1qa gene provided evidence that C1q is necessary for proper clearance of apoptotic cells, since apoptotic corpse accumulated in the kidneys of these animals.31 Furthermore, it was shown that C1q binds to surface blebs of apoptotic keratinocytes.29 The authors concluded that C1q may mediate antibody-independent clearance of apoptotic keratinocytes, and prevents immunisation with autoantigens of cutaneous origin. In addition, experiments with in vitro cultured macrophages showed that the uptake of apoptotic cells was significantly increased in the presence of active serum complement.32 Therefore, under certain conditions complement may contribute to the removal of dying cells. For this reason we investigated the binding of complement components to apoptotic, as well as primary and secondary necrotic cells. Whereas necrotic PBL efficiently bind C3 and C4 immediately after induction of necrosis by heat shock, UVB irradiated PBL executed the early stages of apoptosis without detectable C3 and C4 binding. Similar results had also been observed with induction of apoptosis by treatment with staurosporine or by cultured cells undergoing spontaneous apoptosis (data not shown). We used various methods to analyze cell death. All these methods identified cells as apoptotic before detectable amounts of C1q, C3 and C4 bound to the cells. In the early phases of apoptotic cell death the apoptotic PBL expose PS and become therefore targets for phagocytes expressing the PS receptor.20 Also many other receptors recognising surface changes of apoptotic cells act in the early phases of cell death.18,21,37,38,39 Normally, the removal of dying cells is so efficient that the steady state of apoptotic cells is extremely low even in tissues with very high rates of apoptosis such as thymus or germinal centres of lymph nodes.3 These findings argue for a clearance of most apoptotic cells in the very early phases of apoptosis in vivo. Our in vitro data showed that a marked complement binding could be observed in the late phase of apoptosis, only. This activity is usually preceded by secondary necrosis and is mainly focused on small cells and subcellular fragments. Therefore, complement-mediated uptake of apoptotic cells may primarily represent a back-up mechanism for the clearance of late apoptotic cell material that had escaped first line clearance mechanisms. High local rates of apoptosis and impaired phagocytic capabilities of macrophages represent situations where complement may be necessary for the proper clearance of apoptotic cell material. Interestingly, high rates of apoptosis,40 impaired phagocytosis41 and defects in the components of the classical complement pathway42 are discussed to contribute to the aetiology of human systemic lupus erythematosus. The phagocytic capability for cells in the peripheral blood is relatively low. Dead cells are usually removed from the peripheral blood during the passage of liver or spleen by macrophages of the reticuloendothelial system. Therefore, complement may be involved in the opsonisation and clearance of apoptotic debris that has been trapped in the blood vessels, e.g. in the glomeruli of the kidneys.31
The target structure on apoptotic cells which binds complement is not defined yet. Since secondary necrosis often precedes complement binding, cell surface changes as well as internal structures are candidates for complement activation by late apoptotic cells. Regarding complement binding there were two major differences between PBL and PMN. (I) Heat shocked, primary necrotic PMN bound C3 and C4 much less efficiently than necrotic PBL. (II) In contrast to PBL, in PMN complement binding to subcellular fragments was not preceded by loss of membrane integrity. This observation makes it unlikely that complement binds to internal structures of aged PMN. The prolonged membrane integrity of PMN prevents leakage of toxic compounds from PMN and may be advantageous for the resolution of inflammation. The complement binding of both PMN and PBL takes place in the very late phases of apoptotic cell death and is focused on small cells or subcellular fragments. In contrast to the substantial binding of the complement components C1q, C3 and C4 to small cells or subcellular fragments, the binding of C5 was only marginal. Therefore, it can be concluded that the membrane attack complex is usually not activated by apoptotic or necrotic cells, respectively.
Clearance of apoptotic cells is a very important process which has implications for inflammation, autoimmunity, infectious diseases and tumour vaccination. Defective clearance or reduced anti-inflammatory properties of apoptotic cells may represent important susceptibility factors for autoimmunity.43 Specific plasma proteins like serum amyloid P play an important role in preventing auto-immune diseases. Serum amyloid P binds to apoptotic cells and to nuclear debris released by necrotic cells and regulates the degradation of chromatin.44
Complement is an important humoral defence system, which can initiate and amplify inflammation, even in the preimmune phase when specific antibodies are still lacking and specific lymphocytes are scarce. We suggest that opsonisation of dying cells and subcellular fragments is an important additional feature of complement. Future investigations are necessary to define the molecular targets on dying cells which are recognised and bound by the components of the classical complement pathway.
Materials and Methods
Cells and reagents
Venous blood was drawn from normal healthy volunteers according to institutional guidelines. The blood was anticoagulated by the addition of 20 U/ml heparin. Peripheral blood mononuclear cells were isolated by Ficoll density centrifugation (Lymphoprep™, Gibco-BRL, Eggenstein, Germany). Cells were resuspended in phosphate buffered saline (Gibco-BRL, Eggenstein, Germany) and remaining platelets were removed by centrifugation through fetal calf serum (Gibco-BRL, Eggenstein, Germany). To obtain non-adherent PBMC (PBL) monocytes were removed by adherence to plastic in Dulbecco's modified eagle medium (Gibco-BRL, Eggenstein, Germany). PMN were isolated by density centrifugation using discontinuous gradients of 70% and 62% percoll (Seromed, Berlin, Germany), respectively. Remaining erythrocytes were removed by hypotonic lysis. All cells were cultured in RPMI-1640 medium (Gibco BRL, Eggenstein, Germany) supplemented with 10% heat inactivated fetal calf serum (R10) in a humidified atmosphere containing 5% CO2. As a source of complement or inactivated complement, respectively, the following additions were used: (1) 5% freshly isolated autologous human serum (active complement); and (2) 5% heat inactivated (30 min, 56°C) autologous human serum. This procedure was shown to inactivate the components C1 and C2 of the classical45 and factor B of the alternative complement activation pathway.46
Induction and detection of apoptosis and necrosis
PMN undergo spontaneous progressive apoptosis during the ageing process. Apoptosis of PBL was induced by irradiation with UV-B (120 mJ/cm2). Necrosis of PBL and PMN was induced by incubation of the cells at 56°C for 30 min. Monitoring of apoptosis and necrosis was performed by (1) microscopic examination,47 (2) analysis of morphological changes by flow cytofluorometry (FSC/SSC),48,49 (3) staining with PI in the presence of Triton X-100,50,51 (4) staining with FITC labelled AxV/PI52 and (5) staining with the fluorescent dye 3,3′-dihexyloxacarbocyanine iodide DiO6C(3).53
FITC-labelled annexin-V was purchased from Boehringer Mannheim, Germany. PI, Triton X-100, and DiO6C(3) were obtained from Sigma, Munich, Germany.
Complement binding assay
All cells were cultured in RPMI-1640 medium (Gibco-BRL, Eggenstein, Germany) supplemented with 10% heat inactivated fetal calf serum (R10) in a humidified atmosphere containing 5% CO2. As source of complement the following additives to the culture medium were used: (1) 5% freshly isolated autologous human serum, (2) 5% heat inactivated (30 min, 56°C) autologous human serum. We added an additional 2% of the serum to the cultures 1 h before harvesting the cells to make sure that sufficient active complement is present in the long term cultures. For the detection of bound complement components the cells were harvested, washed with phosphate buffered saline containing 1% heat inactivated fetal calf serum and stained for 30 min on ice with affinity purified, FITC-labelled polyclonal antibodies recognising either C1q, C3c, C4c, or C5 (DAKO, Glostrup, Denmark). For all experiments cells cultured in RPMI-1640 medium supplemented with 10% heat inactivated fetal calf serum in the absence of complement served as negative controls.
Flow cytometric analysis
Analysis of immunofluorescence, FSC/SSC, hypodiploid nuclei, PS exposure, and mitochondrial transmembrane potential (Δψm) was performed employing an EPICS XL™ cytofluorometer (Coulter, Hialeah, USA), typically collecting at least 20 000 events.
Abbreviations
- AS:
-
fresh autologous serum
- AxV:
-
annexin V
- DiO6C(3):
-
fluorescent dye 3,3′-dihexyloxacarbocyanine iodide
- FITC:
-
fluorescein isothiocyanate
- FSC:
-
forward scatter
- IS:
-
heat inactivated autologous serum
- NGH:
-
nuclear granularity and hypochromicity
- PBL:
-
peripheral blood lymphocytes
- PI:
-
propidium iodide
- PMN:
-
polymorphonuclear cells
- PS:
-
phosphatidylserine
- SSC:
-
side scatter
- Δψm:
-
mitochondrial membrane potential
- UVB:
-
ultraviolet B light
References
Earnshaw WC . 1995 Nuclear changes in apoptosis Curr. Opin. Cell. Biol. 7: 337–343
Ellis RE, Jacobson DM, Horvitz HR . 1991 Genes required for the engulfment of cell corpses during programmed cell death in Caernorhabditis elegans Genetics 129: 79–94
Surh CD, Sprent J . 1994 T-cell apoptosis detected in situ during positive and negative selection in the thymus [see comments] Nature 372: 100–103
Buchi ER, Bernauer W, Daicker B . 1994 Cell death and disposal in retinoblastoma: an electron microscopic study Graefes Arch. Clin. Exp. Ophthalmol. 232: 635–645
Peralta Soler A, Mullin JM, Knudsen KA, Marano CW . 1996 Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells Am. J. Physiol. 270: F869–879
Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J . 1994 Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis J. Clin. Invest. 94: 2105–2116
Faa G, Ledda-Columbano GM, Ambu R, Congiu T, Coni P, Riva A, Columbano A . 1994 An electron microscopic study of apoptosis induced by cycloheximide in rat liver Liver 14: 270–278
James TN . 1998 The variable morphological coexistence of apoptosis and necrosis in human myocardial infarction: significance for understanding its pathogenesis, clinical course, diagnosis and prognosis Coron. Artery Dis. 9: 291–307
Ren Y, Savill J . 1998 Apoptosis: the importance of being eaten Cell Death Differ. 5: 563–568
Savill J . 1997 Apoptosis in resolution of inflammation J. Leukoc. Biol. 61: 375–380
Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, Dransfield I, Savill J, Rossi AG . 1999 Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes J. Immunol. 162: 3639–3646
Ren Y, Silverstein RL, Allen J, Savill J . 1995 CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis J. Exp. Med. 181: 1857–1862
Meagher LC, Savill JS, Baker A, Fuller RW, Haslett C . 1992 Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2 J. Leukoc. Biol. 52: 269–273
Stern M, Savill J, Haslett C . 1996 Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response Am. J. Pathol. 149: 911–921
Savill J, Fadok V, Henson P, Haslett C . 1993 Phagocyte recognition of cells undergoing apoptosis Immunol. Today 14: 131–136
Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N . 1998 Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes J. Exp. Med. 188: 1359–1368
Platt N, Suzuki H, Kurihara Y, Kodama T, Gordon S . 1996 Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro Proc. Natl. Acad. Sci. USA 93: 12456–12460
Luciani MF, Chimini G . 1996 The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death EMBO J. 15: 226–235
Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL, Gregory CD . 1998 Human CD14 mediates recognition and phagocytosis of apoptotic cells [see comments] Nature 392: 505–509
Fadok VA, Bratton DL, Rose DN, Pearson A, Alan R, Ezekewitz B, Henson PM . 2000 A receptor for phosphatidylserine-specific clearance of apoptotic cells Nature 405: 85–90
Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM . 1998 The role of phosphatidylserine in recognition of apoptotic cells by phagocytes Cell Death Differ. 5: 551–562
Manfredi AA, Rovere P, Galati G, Heltai S, Bozzolo E, Soldini L, Davoust J, Balestrieri G, Tincani A, Sabbadini MG . 1998 Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies Arthritis Rheum. 41: 205–214
Rovere P, Sabbadini MG, Vallinoto C, Fasciou U, Recigno M, Crosti M, Ricciardi-Castagnoli P, Balestrieri G, Tincani A, Manfredi AA . 1999 Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies Arthritis Rheum. 42: 1412–1420
Rosen A, Casciola-Rosen L, Ahearn J . 1995 Novel packages of viral and self-antigens are generated during apoptosis J. Exp. Med. 181: 1557–1561
Casciola-Rosen L, Rosen A, Petri M, Schlissel M . 1996 Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus Proc. Natl. Acad. Sci. USA 93: 1624–1629
Utz PJ, Hottelet M, Schur PH, Anderson P . 1997 Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus J. Exp. Med. 185: 843–854
Pollard KM, Lee DK, Casiano CA, Bluthner M, Johnston MM, Tan EM . 1997 The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties J. Immunol. 158: 3521–3528
Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A . 1999 Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity J. Exp. Med. 190: 815–826
Korb LC, Ahearn JM . 1997 C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited J. Immunol. 158: 4525–4528
Navratil JS, Korb LC, Ahearn JM . 1999 Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance Immunopharmacology 42: 47–52
Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ . 1998 Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies [see comments] Nat. Genet. 19: 56–59
Mevorach D, Mascarenhas JO, Gershov D, Elkon KB . 1998 Complement-dependent clearance of apoptotic cells by human macrophages J. Exp. Med. 188: 2313–2320
Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM . 1998 The role of phosphatidylserine in recognition of apoptotic cells by phagocytes [see comments] Cell Death Differ. 5: 551–562
Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I . 1997 Immunosuppressive effects of apoptotic cells [letter] Nature 390: 350–351
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM . 1998 Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF J. Clin. Invest. 101: 890–898
Gallucci S, Lolkema M, Matzinger P . 1999 Natural adjuvants: endogenous activators of dendritic cells Nat. Med. 5: 1249–1255
Savill J, Hogg N, Ren Y, Haslett C . 1992 Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis J. Clin. Invest. 90: 1513–1522
Gregory CD . 1998 Phagocytic clearance of apoptotic cells: food for thought [editorial; comment] Cell Death Differ. 5: 549–550
Marguet D, Luciani MF, Moynault A, Williamson P, Chimini G . 1999 Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey Nat. Cell. Biol. 1: 454–456
Lorenz HM, Grunke M, Hieronymus T, Herrmann M, Kuhnel A, Manger B, Kalden JR . 1997 In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases Arthritis Rheum. 40: 306–317
Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR . 1998 Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus Arthritis Rheum. 41: 1241–1250
Kirschfink M, Petry F, Khirwadkar K, Wigand R, Kaltwasser JP, Loos M . 1993 Complete functional C1q deficiency associated with systemic lupus erythematosus (SLE) Clin. Exp. Immunol. 94: 267–272
Rosen A, Casciola-Rosen L . 1999 Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease Cell Death Differ. 6: 6–12
Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB . 1999 Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity [see comments] Nat. Med. 5: 694–697
Linscott WD, Triglia RP . 1981 The bovine complement system Adv. Exp. Med. Biol. 137: 413–430
Ortiz-Ortiz L, Capin R, Capin NR, Sepulveda B, Zamacona G . 1978 Activation of the alternative pathway of complement by Entamoeba histolytica Clin. Exp. Immunol. 34: 10–18
Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J . 1992 Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line Proc. Natl. Acad. Sci. USA 89: 4495–4499
Hagenhofer M, Germaier H, Hohenadl C, Rohwer P, Kalden JR, Herrmann M . 1998 UV-B irradiated cell lines execute programmed cell death in various forms Apoptosis 3: 123–132
Berndt C, Mopps B, Angermuller S, Gierschik P, Krammer PH . 1998 CXCR4 and CD4 mediate a rapid CD95-independent cell death in CD4(+) T cells Proc. Natl. Acad. Sci. USA 95: 12556–12561
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C . 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry J. Immunol. Methods 139: 271–279
Hunakova L, Duraj J, Romanova D, Novotny L, Sedlak J, Kelley MR, Szekeres T, Jayaram HN, Chorvath B . 1998 Staurosporine enhanced benzamide riboside-induced apoptosis in human multidrug-resistant promyelocytic leukemia cells (HL-60/VCR) in vitro Neoplasma 45: 204–209
Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH . 1994 Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis Blood 84: 1415–1420
Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML . 1995 Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis J. Cell. Biol. 130: 157–167
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by A Rosen
Rights and permissions
About this article
Cite this article
Gaipl, U., Kuenkele, S., Voll, R. et al. Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 8, 327–334 (2001). https://doi.org/10.1038/sj.cdd.4400826
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400826
Keywords
This article is cited by
-
Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages
Strahlentherapie und Onkologie (2022)
-
The GAR/RGG motif defines a family of nuclear alarmins
Cell Death & Disease (2021)
-
The human tubal lavage proteome reveals biological processes that may govern the pathology of hydrosalpinx
Scientific Reports (2019)
-
The in vitro immunogenic potential of caspase-3 proficient breast cancer cells with basal low immunogenicity is increased by hypofractionated irradiation
Radiation Oncology (2015)
-
Serum-dependent processing of late apoptotic cells and their immunogenicity
Apoptosis (2015)